Keifei – Retatrutide 3 x 20mg Vials
Original price was: R2,400.00.R2,280.00Current price is: R2,280.00.
Retatrutide is a triple-action receptor agonist targeting GIP, GLP-1, and glucagon receptors. It represents the latest generation of metabolic peptides with three-pathway activation. This product contains 20mg.
In Stock
About Keifei – Retatrutide 3 x 20mg Vials
Retatrutide is a groundbreaking triple-action peptide that simultaneously activates three key metabolic receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors.
Research Areas:
– Weight management through triple receptor activation
– Enhanced metabolic rate via glucagon receptor stimulation
– Appetite suppression and satiety
– Blood sugar regulation
– Energy expenditure increase
By adding glucagon receptor activation to the established GIP/GLP-1 mechanism, retatrutide increases energy expenditure alongside appetite control. Early research has shown promising results, making it one of the most anticipated compounds in metabolic health research.
Delivery Format:
Supplied as a lyophilised (freeze-dried) powder in a sealed vial. Requires reconstitution with bacteriostatic water before use.
Reviews
There are no reviews yet.